Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Fibrocartilaginous embolism

Other Names for this Disease
  • Embolism, fibrocartilaginous
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Tests & Diagnosis

Newline Maker

How is fibrocartilaginous embolism diagnosed?

Initially, all cases of fibrocartilaginous embolism (FCE) were discovered at autopsy. In 1991, the first diagnosis of FCE was made in a patient who survived. Although there are no formal diagnostic criteria for FCE in a living individual, a number of authors have suggested specific features that make the diagnosis likely. These include minor trauma before the event, absence of vascular risk factors, spinal cord imaging consistent with an evolving infarction, normal cerebrospinal fluid (CSF) analysis, and the exclusion of other possible causes.[1]
Last updated: 3/24/2011

  1. F. J. Mateena,b, P. A. Monradb, A. N. Leep Hunderfundb, C. E. Robertsonb and E. J. Sorenson. Clinically suspected fibrocartilaginous embolism: clinical characteristics, treatments, and outcomes. European Journal of Neurology. 2011; 18:218-225.